Cargando…
Lights and Shadows in Immuno-Oncology Drug Development
SIMPLE SUMMARY: The introduction of immunotherapy has had a significant impact on the cancer treatment landscape, with unprecedented survival outcomes in some tumor types. However, clinical development of immune-oncology (IO) agents presents both opportunities and challenges, and not all patients be...
Autores principales: | Bergamino Sirvén, Milana, Pernas, Sonia, Cheang, Maggie C. U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915946/ https://www.ncbi.nlm.nih.gov/pubmed/33572060 http://dx.doi.org/10.3390/cancers13040691 |
Ejemplares similares
-
Quantitative Translation in Immuno‐Oncology Research and Development
por: Bottino, Dean, et al.
Publicado: (2020) -
Harnessing αβ T cell receptor mechanobiology to achieve the promise of immuno-oncology
por: Reinherz, Ellis L., et al.
Publicado: (2023) -
Nomograms in Urologic Oncology: Lights and Shadows
por: Morlacco, Alessandro, et al.
Publicado: (2021) -
Targeted Therapeutic Options and Future Perspectives for HER2-Positive Breast Cancer
por: Ferrando-Díez, Angelica, et al.
Publicado: (2022) -
Development of a “Surgical Shadowing Scheme” to improve undergraduate experiences of surgery
por: Bartlett, Richard D, et al.
Publicado: (2019)